Table 5 Sequences of peptides used for the ELISPOT-screen in the Vienna laboratory at Intercell AG.
From: Clearance of low levels of HCV viremia in the absence of a strong adaptive immune response
| Â | HCV | Â | HLA coverage | |
|---|---|---|---|---|
ID | antigen | amino acid sequence | class I | class II |
1798 | NS4 | IGLGKVLVDILAGYGAGVAGALVAFK | A2, 3, 11 | DR1, 4, 7 |
1799 | NS3 | AAWYELTPAETTVRLR | B7/B35 | DR1, 4 |
1624 | E2 | LEDRDRSELSPLLLSTTEW | B*4001 | DR7 |
1547 | NS3 | YLVAYQATVCARAQAPPPSWD | A2 | DR1, 4, 7, 11 |
1827 | NS3 | TAYSQQTRGLLG | A24, B8? | DR1, 7, 11 |
1829 | NS5 | SMSYTWTGALITP | A2, B7, A24? | DR1, 7, 11? |
1846 | E2 | DYPYRLWHYPCTVNFTIFKV | Cw7, A2, A11? | DR1, 4, 7, 11 |
1754 | E2 | DYPYRLWHY | Cw7 | Â |
1835 | Core | KFPGGGQIVGGVYLLPRRGPRLGVRATRK | A2, A3, B7 | DR11 |
1855 | NS5 | SAKSKFGYG | B8? | Â |
1843 | Core | LPRRGPRL | B7 | Â |
1844 | Core | GPRLGVRAT | B7 | Â |
1818 | NS3 | TPAETTVRL | B7/B35 | Â |
1838 | NS4 | SPGALVVGVI | B7 | Â |
1557 | NS5 | SSMPPLEGEPGDPDL | B*4402? | Â |